156 related articles for article (PubMed ID: 70930)
21. A reappraisal of the use of 5-methoxypsoralen in the therapy of psoriasis.
Calzavara-Pinton P; Ortel B; Carlino A; Honigsmann H; De Panfilis G
Exp Dermatol; 1992 Jul; 1(1):46-51. PubMed ID: 1344660
[TBL] [Abstract][Full Text] [Related]
22. Topical methoxsalen and blacklight in the treatment of psoriasis.
Petrozzi JW; Kaidbey KM; Kligman AM
Arch Dermatol; 1977 Mar; 113(3):292-6. PubMed ID: 843094
[TBL] [Abstract][Full Text] [Related]
23. Interaction between 8-methoxypsoralen and phenytoin. Consequence for PUVA therapy.
Staberg B; Hueg B
Acta Derm Venereol; 1985; 65(6):553-5. PubMed ID: 2420126
[TBL] [Abstract][Full Text] [Related]
24. Photochemotherapy and the eye: photoprotective factors.
Glew WB; McKeever G; Roberts WP; Malinin G; Nigra TP
Trans Am Ophthalmol Soc; 1980; 78():243-54. PubMed ID: 7257058
[TBL] [Abstract][Full Text] [Related]
25. Psoralen cream plus ultraviolet A photochemotherapy (PUVA cream): our experience.
Pozo-Román T; González-López A; Velasco-Vaquero ME; Núñez-Cabezón M
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):136-42. PubMed ID: 16441619
[TBL] [Abstract][Full Text] [Related]
26. Treatment of psoriasis with orally administered 8-methoxypsoralen and long-wavelength ultraviolet radiation.
Wasserman GA; Llewellyn MW; Ramsay CA; Haberman HF
Can Med Assoc J; 1978 Jun; 118(11):1379-83. PubMed ID: 657030
[TBL] [Abstract][Full Text] [Related]
27. [8-methoxypsoralen serum content of problem patients in PUVA therapy].
Walther T; Haustein UF
Dermatol Monatsschr; 1990; 176(5-6):317-21. PubMed ID: 2227049
[TBL] [Abstract][Full Text] [Related]
28. Molecular aspects of extracorporeal photochemotherapy.
Gasparro FP; Dall'Amico R; Goldminz D; Simmons E; Weingold D
Yale J Biol Med; 1989; 62(6):579-93. PubMed ID: 2700057
[TBL] [Abstract][Full Text] [Related]
29. Inefficacy of topical methoxalen plus UVA for palmoplantar pustulosis.
Jansén CT; Malmiharju T
Acta Derm Venereol; 1981; 61(4):354-6. PubMed ID: 6173996
[TBL] [Abstract][Full Text] [Related]
30. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
[TBL] [Abstract][Full Text] [Related]
31. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
Nimkulrat P; Leenutaphong V; Sudtim S
J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
[TBL] [Abstract][Full Text] [Related]
32. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen.
Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH
J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009
[TBL] [Abstract][Full Text] [Related]
33. Acute effect of 8-methoxypsoralen and ultraviolet light on sister chromatid exchange.
Wulf HC
Arch Dermatol Res; 1978 Sep; 263(1):37-46. PubMed ID: 718262
[TBL] [Abstract][Full Text] [Related]
34. Psoralen-UVA-treated psoriatic lesions. Ultrastructural changes.
Hashimoto K; Kohda H; Kumakiri M; Blender SL; Willis I
Arch Dermatol; 1978 May; 114(5):711-22. PubMed ID: 646392
[TBL] [Abstract][Full Text] [Related]
35. Palmoplantar psoriasis: experience with 8-methoxypsoralen soaks plus ultraviolet A with the use of a high-output metal halide device.
Coleman WR; Lowe NJ; David M; Halder RM
J Am Acad Dermatol; 1989 Jun; 20(6):1078-82. PubMed ID: 2754058
[TBL] [Abstract][Full Text] [Related]
36. Treatment of psoriasis with psoralens and ultraviolet A. A double-blind comparison of 8-methoxypsoralen and 5-methoxypsoralen.
Berg M; Ros AM
Photodermatol Photoimmunol Photomed; 1994 Oct; 10(5):217-20. PubMed ID: 7880762
[TBL] [Abstract][Full Text] [Related]
37. [Photochemotherapy of cutaneous lymphoma: oral and local 8-MOP-UVA treatment (author's transl)].
Hofmann C; Burg G; Plewig G; Braun-Falco O
Dtsch Med Wochenschr; 1977 May; 102(18):675-9. PubMed ID: 142005
[TBL] [Abstract][Full Text] [Related]
38. [Photochemotherapy of psoriasis: increasing its effectiveness with an oral aromatic retinoid (clinical results in 134 patients) (author's transl)].
Fritsch P; Hönigsmann H; Jaschke E; Wolff K
Dtsch Med Wochenschr; 1978 Nov; 103(44):1731-6. PubMed ID: 361362
[TBL] [Abstract][Full Text] [Related]
39. 8-MOP plasma levels in PUVA problem cases with psoriasis.
Wagner G; Hofmann C; Busch U; Schmid J; Plewig G
Br J Dermatol; 1979 Sep; 101(3):285-92. PubMed ID: 508594
[TBL] [Abstract][Full Text] [Related]
40. The effect of methoxsalen dose on ultraviolet-A-induced erythema.
Ibbotson SH; Dawe RS; Farr PM
J Invest Dermatol; 2001 May; 116(5):813-5. PubMed ID: 11348476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
